Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer
Clinical trial NCT06712472 · RECRUITING
Trial details
- NCT number
- NCT06712472
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-26
- Primary completion
- 2030-06-01
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.